Keisuke Ozaki

810 citations
42 papers · 677 indexed · h-index 15

Keisuke Ozaki

38 papers receiving 650 citations

Peers

Keisuke Ozaki
Comparison fields: 5 of 93
  • Cancer Research 154
  • Reproductive Medicine 86
  • Chemical Health and Safety 5
  • Aging 9
  • Public Health, Environmental and Occupational Health 137
Replace Ying Zhong with:
Ying Zhong China
V. S. Turusov France
Anna Szpila Poland
Jolanta Guz Poland
Dilip Kumar Sinha United States
Hiroshi Kasai Japan
Ryo Fukunishi Japan
R.C. Garner United Kingdom
Tokuo Sukata Japan
Keisuke Ozaki relative to Ying Zhong China Ying Zhong's profile →
Citations per field
00.5×4.5×
Ying Zhong · 1×
Citations per year

Countries citing papers authored by Keisuke Ozaki

Since Specialization
Citations

This map shows the geographic impact of Keisuke Ozaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keisuke Ozaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keisuke Ozaki more than expected).

Fields of papers citing papers by Keisuke Ozaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keisuke Ozaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keisuke Ozaki. The network helps show where Keisuke Ozaki may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Keisuke Ozaki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Keisuke Ozaki Line = papers co-authored together Keisuke Ozaki links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20232
2 20214
3 20198
4 201725
5 201412
6 200421
7 200239
8 199815
9 19971
10 19961
11 1996147
12 199535
13 19947
14 19935
15 19927
16 19926
17 199168
18 199014
19 199013
20
Simple determination of glycine/taurine ratio of conjugated bile acids in human gallbladder bile.
19770

About Keisuke Ozaki

Keisuke Ozaki is a scholar working on Cancer Research, Reproductive Medicine and Pharmacology, having authored 42 papers that have together received 677 indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (8 papers), Genomics, phytochemicals, and oxidative stress (5 papers), Glutathione Transferases and Polymorphisms (4 papers), Bladder and Urothelial Cancer Treatments (4 papers), Reproductive Biology and Fertility (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Sperm and Testicular Function (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). The work is most often cited by research in Cancer Research (154 citations), Reproductive Medicine (86 citations) and Chemical Health and Safety (5 citations). Keisuke Ozaki has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Satoshi Uwagawa, Tokuo Sukata, Shoji Fukushima, Fumihiro Ito, Eisuke F. Sato, Sachio Ogita, Eiji Hayashi, Nobuyuki Ito, M. Inoue and Katsumi Takaba. Their work appears in journals such as The Journal of Urology, American Journal Of Pathology and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026